Medicago, a biotech out of Quebec City Canada that  is expecting to enter clinical trials with an avian flu vaccine this year,  has just announced, only 14 days after receiving the DNA sequence for the influenza A (H1N1) virus,  positive results on an immunogenicity study in mice. Results demonstrated that the Company’s H1 VLP vaccine […]